{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:31:26Z","timestamp":1760059886725,"version":"build-2065373602"},"reference-count":44,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Gastric cancer treatment of partial or complete gastrectomy includes lymph nodes dissection (D2) to remove microscopic lymph node metastases adjacent to the tumor. A more extensive approach, an extended dissection (D2plus) has recently been employed, which includes resection of the lymph nodes in the pancreatic and periportal areas. However, despite its potential benefits of longer survival for patients diagnosed with advanced cancer, there are increased risks due to surgical complications. The current study aims to examine the balance between clinical benefit and higher risks of the extended dissection approach versus standard dissection. Materials and Methods: This retrospective analysis of gastric cancer patients treated in Bnai-Zion medical center examined the survival rates, oncological outcomes, and complication rates according to medical records data files. Results: The D2plus group experienced increased postoperative complications rate (56% vs. 20.6% D2 group p = 0.005) with mean survival time, shorter than the D2 standard approach (2.07 years vs. 3.44 years p = 0.01). A higher number of lymph nodes was removed on average in the D2plus group (29.4 \u00b1 11.2), but without statistical significance in comparison to the D2 group (22.6 \u00b1 8.9, p = 0.013). D2plus patients had reduced disease recurrence rates (20% vs. 32.4% in D2 group p = 0.29). Weight loss of D2plus patients was noted for higher rates than the D2 group (40% vs. 17.6% p = 0.056. Conclusions: Our study provides preliminary insights into the comparison between D2 and D2plus dissection in a single-center Western cohort. However, significant baseline differences between groups, particularly age, gender, and histopathological characteristics, limit definitive conclusions. The findings should be interpreted as hypothesis-generating rather than practice-changing. Larger, prospective, multicenter studies with propensity score matching or randomized design are needed to definitively establish the optimal surgical approach for different patient subgroups.<\/jats:p>","DOI":"10.3390\/medicina61071284","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:48:22Z","timestamp":1752680902000},"page":"1284","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Extended Dissection of Lymph Nodes (D2plus) with Gastrectomy on the Clinical and Oncological Outcomes in Gastric Cancer Patients, Compared to a Standard Dissection (D2)"],"prefix":"10.3390","volume":"61","author":[{"given":"Sahar","family":"Lazari","sequence":"first","affiliation":[{"name":"Department of Pediatric Surgery, Rambam Health Care Campus, 8 HaAliya HaShniya Street, Haifa 3109601, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3721-6505","authenticated-orcid":false,"given":"Muhammad","family":"Masalha","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tzafon Medical Center, Poriya 1528001, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Forat","family":"Swaid","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tzafon Medical Center, Poriya 1528001, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7570-4550","authenticated-orcid":false,"given":"Walid","family":"Shalata","sequence":"additional","affiliation":[{"name":"The Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Ben-Gurion University, Beer Sheva 84105, Israel"},{"name":"Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon","family":"Sroka","sequence":"additional","affiliation":[{"name":"Department of Surgery, Bnai-Zion Medical Center, 47 Eliyahu Golomb Avenue, Haifa 3339419, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weam","family":"Waked","sequence":"additional","affiliation":[{"name":"Department of Surgery, Bnai-Zion Medical Center, 47 Eliyahu Golomb Avenue, Haifa 3339419, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3330-2959","authenticated-orcid":false,"given":"Abed","family":"Agbarya","sequence":"additional","affiliation":[{"name":"Institute of Oncology, Bnai-Zion Medical Center, 47 Eliyahu Golomb Avenue, Haifa 3339419, Israel"},{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, 1 Efron Street, Haifa 3339101, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","article-title":"Gastric cancer: A comprehensive review of current and future treatment strategies","volume":"39","author":"Sexton","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1470-2045(10)70070-X","article-title":"Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial","volume":"11","author":"Songun","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Mamun, T.I., Younus, S., and Rahman, H. (2024). Gastric cancer\u2014Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated review. Cancer Treat. Res. Commu., 41.","DOI":"10.1016\/j.ctarc.2024.100845"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/08998280.2004.11928001","article-title":"Adenocarcinoma of the stomach: A review","volume":"17","author":"McLoughlin","year":"2004","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3748\/wjg.v17.i9.1180","article-title":"Prognostic factors of T4 gastric cancer patients undergoing potentially curative resection","volume":"17","author":"Fukuda","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer Association (1998). Japanese Classification of Gastric Carcinoma, 2nd English edition. Gastric Cancer, 1, 10\u201324.","DOI":"10.1007\/PL00011681"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.47717\/turkjsurg.2020.4931","article-title":"D2 vs D2 Plus Para-aortic Lymph node dissection for Advanced Gastric Cancer","volume":"37","author":"Ozmen","year":"2020","journal-title":"Turk. J. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Li, J.Q., He, D., and Liang, Y.X. (2021). Current status of extended \u2018D2 plus\u2019 lymphadenectomy in advanced gastric cancer. Oncol. Lett., 21.","DOI":"10.3892\/ol.2021.12728"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.3748\/wjg.v22.i10.2875","article-title":"Gastric cancer: Current status of lymph node dissection","volume":"22","author":"Degiuli","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer Association (2017). Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer, 20, 1\u201319.","DOI":"10.1007\/s10120-016-0622-4"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Nico, R., Veziant, J., Chau, A., Eveno, C., and Piessen, G. (2024). Optimal lymph node dissection for gastric cancer: A narrative review. World J. Surg. Oncol., 22.","DOI":"10.1186\/s12957-024-03388-4"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5230\/jgc.2012.12.2.55","article-title":"Comparisons of Gastric Treatments: East vs. West","volume":"12","author":"Bickenbach","year":"2012","journal-title":"J. Gastric Cancer"},{"key":"ref_14","unstructured":"Yamamoto, M., Rashid, O.M., and Wong, J. (2015). Surgical management of gastric cancer: The East vs. West perspective. J. Gastrointest. Oncol., 6."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1200\/JCO.1998.16.4.1490","article-title":"Morbidity and mortality after D2 gastrectomy for gastric cancer: Results of the Italian Gastric Cancer Study Group prospective multicenter surgical study","volume":"16","author":"Degiuli","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Back, J., Sallinen, V., Kokkola, A., and Puolakkainen, P. (2022). Surgical and oncological outcomes of D1 versus D2 gastrectomy among elderly patients treated for gastric cancer. Scand. J. Surg., 111.","DOI":"10.1177\/14574969221096193"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2021.03.031","article-title":"D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial","volume":"150","author":"Degiuli","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-Giraldo, C., Avenda\u00f1o-Morales, V., Van-Londo\u00f1o, I., Melo-Leal, D., Camargo-Areyanes, M.I., Venegas-Sanabria, L.C., Varags Varags, J.P., Aguirre-Salamanca, E.J., and Isaza-Restrepo, A. (2024). Lymph Node Dissection of Choice in Older Adult Patients with Gastric Cancer: A Systematic Review and Meta-Analysis. J. Clin. Med., 13.","DOI":"10.3390\/jcm13247678"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1245\/s10434-022-11480-w","article-title":"Comparison of Standard D2 and Limited Lymph Node Dissection in Elderly Patients with Advanced Gastric Cancer","volume":"29","author":"Ko","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hsu, J.T., Lin, Y.N., Chen, Y.F., Kou, H.W., Wang, S.Y., Chou, W.C., Wu, T.R., and Yeh, T.S. (2024). A comprehensive overview of gastric cancer management from a surgical point of view. Biomed. J., in press.","DOI":"10.1016\/j.bj.2024.100817"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Marano, L., Carbone, L., Poto, G.E., Restaino, V., Piccioni, S.A., Verre, L., Roviello, F., and Marrelli, D. (2022). The Percentage of Signet Ring Cells Is Inversely Related to Aggressive Behavior and Poor Prognosis in Mixed-Type Gastric Cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.897218"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ejso.2021.09.003","article-title":"Signet ring cell percentage in poorly cohesive gastric cancer patients: A potential novel predictor of survival","volume":"48","author":"Roviello","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Dinescu, V.C., Gheorman, V., Georgescu, E.F., Paitici, \u0218., Bic\u0103, M., P\u0103tra\u0219cu, \u0218., Bunescu, M.G., Popa, R., Berceanu, M.C., and P\u0103tra\u0219cu, A.M. (2023). Uncovering the Impact of Lymphadenectomy in Advanced Gastric Cancer: A Comprehensive Review. Life, 13.","DOI":"10.3390\/life13081769"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.7314\/APJCP.2015.16.5.2055","article-title":"Treatment Outcomes and Survival Study of Gastric Cancer Patients: A Retrospective Analysis in an Endemic Region","volume":"16","author":"Basaran","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Liang, Y., Cui, J., Cai, Y., Liu, L., Zhou, J., Li, Q., Wu, J., and He, D. (2019). \u201cD2 plus\u201d lymphadenectomy is associated with improved survival in distal gastric cancer with clinical serosa invasion: A propensity score analysis. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-55535-7"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/curroncol30010067","article-title":"Extended lymphadenectomy for gastric cancer in the neoadjuvant era: Current status, clinical implications and contentious issues","volume":"30","author":"Marano","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3748\/wjg.v16.i9.1138","article-title":"Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer","volume":"16","author":"Wang","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sch\u00fctte, K., Schulz, C., and Middelberg-Bisping, K. (2021). Impact of gastric cancer treatment on quality of life of patients. Best Pract. Res. Clin. Gastroenterol., 50.","DOI":"10.1016\/j.bpg.2021.101727"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Barone, M., Prioletta, M., Di Nuzzo, D., Ippoliti, M., Cipollone, G., and Mucilli, F. (2020). Conventional vs. extended D2 lymphadenectomy in gastric cancer patients: Less is more?\u2014More or less. Dig. Med. Res., 3.","DOI":"10.21037\/dmr-20-103"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11605-015-3049-z","article-title":"Diagnosis and Treatment of Abdominal Arterial Bleeding After Radical Gastrectomy: A Retrospective Analysis of 1875 Consecutive Resections for Gastric Cancer","volume":"20","author":"Yang","year":"2016","journal-title":"J. Gastrointest. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ags3.12398","article-title":"Postoperative pancreatic fistula after gastrectomy for gastric cancer","volume":"4","author":"Washio","year":"2020","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cmrp.2014.11.005","article-title":"Controversies in management of gastric cancer","volume":"4","author":"Parray","year":"2014","journal-title":"Curr. Med. Res. Prac."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejso.2011.01.013","article-title":"Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection","volume":"37","author":"Biffi","year":"2011","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJMoa0707035","article-title":"D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer","volume":"359","author":"Sasako","year":"2008","journal-title":"N. Eng. J. Med."},{"key":"ref_35","first-page":"389","article-title":"Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: A prospective randomized trial conducted by Asian surgeon","volume":"53","author":"Yonemura","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Yu, P.F., Du, Y., Xu, Z., Huang, L., and Cheng, X. (2019). Comparison of D2 and D2plus surgery for advanced distal gastric cancer. World J. Surg. Oncol., 17.","DOI":"10.1186\/s12957-019-1572-1"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2169\/internalmedicine.47.0975","article-title":"Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains","volume":"47","author":"Yamaoka","year":"2008","journal-title":"Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Jalaeefar, A., Mousavi, S.Z., Shirkhoda, M., Mahmoodzadeh, H., Mohammadzadeh, N., and Sharifi, A. (2024). Is there any difference between Eastern and Western clinical practice guidelines in management of gastric cancer?. Cancer Rep., 7.","DOI":"10.1002\/cnr2.2076"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s10038-021-00960-8","article-title":"Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations","volume":"66","author":"Katoh","year":"2021","journal-title":"J. Hum. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lopez, M.J., Carbajal, J., Alfaro, A.L., Saravia, L.G., Zanabria, D., Araujo, J.M., Quispe, L., Zevallos, A., Buleje, J.L., and Ehunbee Cho, C. (2023). Characteristics of gastric cancer around the world. Crit. Rev. Oncol. Hematol., 181.","DOI":"10.1016\/j.critrevonc.2022.103841"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ags3.12788","article-title":"Impact of malnutrition and nutritional support after gastrectomy in patients with gastric cancer","volume":"8","author":"Kang","year":"2024","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Marrelli, D., Piccioni, S.A., Carbone, L., Petrioli, R., Costantini, M., Malagnino, V., Bagnacci, G., Rizzoli, G., Calomino, N., and Piagnerelli, R. (2024). Posterior and Para-Aortic (D2plus) Lymphadenectomy after Neoadjuvant\/Conversion Therapy for Locally Advanced\/Oligometastatic Gastric Cancer. Cancers, 16.","DOI":"10.3390\/cancers16071376"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ags3.12191","article-title":"Surgery with curative intent for stage IV gastric cancer: Is it a reality of illusion?","volume":"2","author":"Kodera","year":"2018","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kalavacherla, S., Neel, N., Jagadeesh, V., Bouvet, M., Lowy, A., Horgan, S., Kelly, K.J., and Mehtsun, W.T. (2025). Survival Outcomes Between Minimally Invasive and Open Gastrectomy in Early and Locally Advanced Gastric Adenocarcinoma in a Western Center. J. Gastrointest. Cancer., 56.","DOI":"10.1007\/s12029-024-01163-y"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1284\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:10:50Z","timestamp":1760033450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071284"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071284","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}